Annals of the Rheumatic Diseases: 80 (12)

Editorial

Towards clinical significance of the MUC5B promoter variant and risk of rheumatoid arthritis-associated interstitial lung disease
(3 August, 2021) Free
Jeffrey A Sparks

Viewpoint

Nothing about us without us: involving patient collaborators for machine learning applications in rheumatology (5 July, 2021)
Stephanie J W Shoop-Worrall, Katherine Cresswell, Imogen Bolger, Beth Dillon, Kimme L Hyrich, Nophar Geifman

Review

Axial spondyloarthritis (6 October, 2021)
Victoria Navarro-Compán, Alexandre Sepriano, Bassel El-Zorkany, Désirée van der Heijde

Rheumatoid arthritis

Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis (2 July, 2021) Free
Anthony James Ocon, George Reed, Dimitrios A Pappas, Jeffrey R Curtis, Joel M Kremer
Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers
(3 August, 2021)
Antti Palomäki, FinnGen Rheumatology Clinical Expert Group, Aarno Palotie, Jukka Koskela, Kari K Eklund, Matti Pirinen, FinnGen, Samuli Ripatti, Tarja Laitinen, Nina Mars
B cell depletion impairs vaccination-induced CD8⁺ T cell responses in a type I interferon-dependent manner
(5 July, 2021)
Theresa Graalmann, Katharina Borst, Himanshu Manchanda, Lea Vaas, Matthias Bruhn, Lukas Graalmann, Mario Koster, Murielle Verboom, Michael Hallensleben, Carlos Alberto Guzmán, Gerd Sutter, Reinhold E Schmidt, Torsten Witte, Ulrich Kalinke

Inflammatory arthritis

Impaired fertility in men diagnosed with inflammatory arthritis: results of a large multicentre study (iFAME-Fertility) (9 August, 2021)
Luis Fernando Perez-Garcia, Esther Röder, Robbert J Goekoop, Johanna M W Hazes, Marc R Kok, Hieronymus T W Smeele, Ilja Tchetverikov, Annette H M van der Helm-van Mil, Jos H van der Kaap, Petra Kok, Bouwe P Krijthe, Radboud J E M Dolhain

Psoriatic arthritis

Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgia (2 July, 2021)
Ari Polachek, Victoria Furer, Mirna Zureik, Sharon Nevo, Liran Mendel, David Levartovsky, Jonathan Wollman, Valerie Aloush, Reut Tzemach, Ofir Elalouf, Marina Anouk, Mark Berman, Ilana Kaufman, Or Carmi, Yael Lahat, Tali Eviatar, Hagit Padova, Hagit Sarbagil-Maman, Sara Borok, Adi Broyde, Lihi Eder, Daphna Paran, Ori Elkayam
Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid (5 July, 2021)
Nicole Yager, Suzanne Cole, Alicia Lledo Lara, Ash Maroof, Frank Penkava, Julian C Knight, Paul Bowness, Hussein Al-Mossawi

Systemic lupus erythematosus

Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity (18 August, 2021)
Diogo Jesus, Maddalena Larosa, Carla Henriques, Ana Matos, Margherita Zen, Paulo Tomé, Valter Alves, Nuno Costa, Véronique Le Guern, Luca Iaccarino, Nathalie Costedoat-Chalumeau, Andrea Doria, Luís Sousa Inês
Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese (23 August, 2021)
Yoshihiko Tomofuji, Yuichi Maeda, Eri Oguro-Igashira, Toshihiro Kishikawa, Kenichi Yamamoto, Kyuto Sonehara, Daisuke Motooka, Yuki Matsumoto, Hidetoshi Matsuoka, Maiko Yoshimura, Mayu Yagita, Takuro Nii, Shiro Ohshima, Shota Nakamura, Hidenori Inohara, Kiyoshi Takeda, Atsushi Kumanogoh, Yukinori Okada

Systemic sclerosis

Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis (6 July, 2021)
Kristina Elizabeth Neergaard Clark, Corrado Campochiaro, Eszter Csomor, Adam Taylor, Katherine Nevin, Nicholas Galwey, Mary A Morse, Jennifer Singh, Yee Voan Teo, Voon H Ong, Emma Derrett-Smith, Nicolas Wisniacki, Shaun M Flint, Christopher P Denton
TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis (20 July, 2021)
Paôline Laurent, Benoit Allard, Pauline Manicki, Valérie Jolivel, Emeline Levionnois, Mohamed Jeljeli, Pauline Henrot, Julien Izotte, Damien Leleu, Alexis Groppi, Julien Seneschal, Joel Constans, Carlo Chizzolini, Christophe Richez, Pierre Duffau, Estibaliz Lazaro, Edouard Forcade, Thierry Schaeverbeke, Thomas Pradeu, Frédéric Batteux, Patrick Blanco, Cécile Contin-Bordes, Marie-Elise Truchetet

Crystal arthritis

Mechanosensitive TRPV4 is required for crystal-induced inflammation (18 October, 2021)
Zhou Lan, Lvyi Chen, Jing Feng, Zili Xie, Zhiyong Liu, Fang Wang, Peng Liu, Xueping Yue, Lixia Du, Yonghui Zhao, Pu Yang, Jialie Luo, Zhe Zhu, Xueming Hu, Liang Cao, Ping Lu, Rajan Sah, Kory Lavine, Brian Kim, Hongzhen Hu

Osteoarthritis

14-3-3 epsilon is an intracellular component of TNFR2 receptor complex and its activation protects against osteoarthritis (5 July, 2021)
Wenyu Fu, Aubryanna Hettinghouse, Yujianan Chen, Wenhuo Hu, Xiang Ding, Meng Chen, Yuanjing Ding, Jyoti Mundra, Wenhao Song, Ronghan Liu, Young-Su Yi, Mukundan Attur, Jonathan Samuels, Eric Strauss, Philipp Leucht, Ran Schwarzkopf, Chuan-ju Liu

Letters

Early reduction in circulating monocyte count predicts maintenance of remission in patients with rheumatoid arthritis treated with anti-TNF therapy (23 June, 2021)
Muhammad Ruhul Amin Shipa, Raj Amarnani, Su-Ann Yeoh, M D Mainuddin, Michael R Ehrenstein
Nail involvement in psoriatic arthritis patients is an independent risk factor for carotid plaque (24 June, 2021)
Iris Jazmin Colunga-Pedraza, Dionicio Angel Galarza-Delgado, Jose Ramon Azpiri-Lopez, Alejandra Berenice Rodriguez-Romero, Natalia Guajardo-Jauregui, Jesus Alberto Cardenas-de la Garza, Salvador Lugo-Perez, Alejandro Meza-Garza, Julieta Loya-Acosta, Andrea Cecilia Garza-Acosta
Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study (6 August, 2021)
Yun Liu, Zongfei Ji, Wensu Yu, Sifan Wu, Huiyong Chen, Lili Ma, Zhenqi Ding, Lindi Jiang
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System (20 July, 2021)
Maximilian Pistor, Andreas G F Hoepner, Yanan Lin, Simon Jung, Claudio L Bassetti, Andrew Chan, Anke Salmen, Robert Hoepner
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis (25 June, 2021)
Serena Bugatti, Ludovico De Stefano, Silvia Balduzzi, Maria Immacolata Greco, Terenzj Luvaro, Irene Cassaniti, Laura Bogliolo, Iolanda Mazzucchelli, Bernardo D’Onofrio, Michele di Lernia, Eleonora Mauric, Daniele Lilleri, Fausto Baldanti, Antonio Manzo, Carlomaurizio Montecucco
Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritis (29 June, 2021)
Sophie De Mits, Ann-Sophie De Craemer, Liselotte Deroo, Thomas Renson, Filip E Van den Bosch, Philippe Carron, Dirk Elewaut

Electronic pages

European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist’s point of view (22 November, 2019) Free
Maria Infantino, Mariangela Manfredi, Nicola Bizzaro
Response to: ‘European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view’ by Infantino et al
(12 December, 2019) Free
Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson
New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion (6 December, 2019) Free
Karim Sacre, Laure Delaval, Antoine Dossier, Jean-Francois Alexandra, Marie Berleur, Marie-Paule Chauveheid, Gregory Ducrocq, Tiphaine Goulenok, Damien van Gysel, Diane Rouzaud, Thomas Papo
Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion’ by Sacre et al
(20 December, 2019) Free
Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson
Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus (6 December, 2019) Free
Bin Wang, Shiju Chen, Qing Zheng, Zhenyu Gao, Rongjuan Chen, Jingxiu Xuan, Yuan Liu, Guixiu Shi
Response to: ‘Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus’ by Wang et al
(20 December, 2019) Free
Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson
NCF1-339 polymorphism and systemic lupus erythematosus (28 November, 2019) Free
Beuy Joob, Viroj Wiwanitkit
Response to: ‘NCF1-339 polymorphism and systemic lupus erythematosus’ by Joob and Wiwanitkit (9 December, 2019) Free
Carl Petrus Linge, Anders Bengtsson
Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors (19 November, 2019) Free
Anja Meyer, Paula S Wittekind, Konstantin Kotschenreuther, Joanna Schiller, Julia von Tresckow, Thomas H Haak, David M Kofler
Response to: ‘Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors’ by Meyer et al
(21 January, 2020) Free
Michelle Rosenzwajg, Roberta Lorenzon, David Klatzmann
Correspondence to ‘Slope sign’: a feature of large vessel vasculitis? (27 November, 2019) Free
Marcin Milchert, Marek Brzosko, Anne Bull Haaversen, Andreas P Diamantopoulos
Response to: ‘Correspondence to ‘Slope sign’: a feature of large vessel vasculitis?’ by Milchert et al
(11 December, 2019) Free
Alwin Sebastian, Abdul Kayani, Bhaskar Dasgupta
Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares (2 December, 2019) Free
Arnaud M Didierlaurent, Christophe Desssart, Anthony L Cunningham
Response to: ‘Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares’ by Didierlaurent et al
(18 December, 2019) Free
Chio Yokose, Hyon Choi
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care (27 November, 2019) Free
Konstantinos Parperis
Response to: ‘Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care’ by Parperis et al
(4 December, 2019) Free
Edward Roddy, Christian D Mallen
Association between osteoporosis and statins therapy: the story continues (19 November, 2019) Free
Andrea Michelle Burden, Stefan Weiler
Response to: ‘Association between osteoporosis and statin therapy: the story continues’ by Burden and Weiler (4 December, 2019) Free
Michael Leutner, Caspar Matzhold, Luise Bellach, Carola Deischinger, Jürgen Harreiter, Stefan Thurner, Peter Klimek, Alexandra Kautzky-Willer

Main menu

Table of contents

December 2021 - Volume 80 - 12

Editorial

Viewpoint

Review

Rheumatoid arthritis

Inflammatory arthritis

Psoriatic arthritis

Systemic lupus erythematosus

Systemic sclerosis

Crystal arthritis

Osteoarthritis

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

December 2021 - Volume 80 - 12

Editorial

Viewpoint

Review

Rheumatoid arthritis

Inflammatory arthritis

Psoriatic arthritis

Systemic lupus erythematosus

Systemic sclerosis

Crystal arthritis

Osteoarthritis

Letters

Electronic pages

Issue Information